Effects of Oncological Treatment During Pregnancy on Mother and Child

StatusRecruiting
PhaseNot specified
Started

Record status This record was last updated March 6, 2024 (before its estimated April 2025 completion). Its status may not reflect the trial's current state.

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 28 words
    • Study description shortened, about 53 words
    • Site contacts updated at 1 of 33 sites
    • Collaborators revised (5)
    v15
  2. Re-verified, no change to tracked fieldsv14
  3. Study sites revised (33)v13
  4. Study sites: 11 to 33v12
  5. Study sites: 5 to 11
    • Collaborators: 10 to 5
    v11
Show 9 earlier versionsHide 9 earlier versions
  1. Study sites: 1 to 5v10 Show 6 more changesShow less
    • Study completion date: Apr 2025 to Dec 2032
    • Eligibility criteria expanded, about 19 words
    • Study description expanded, about 237 words
    • Collaborators: 6 to 10
    • Publications: 42 to 73
    • Study title expanded, about 4 words
  2. Primary and study completion dates: Apr 2020 to Apr 2025
    • Publications: 18 to 42
    • Eligibility criteria expanded, about 2 words
    v9
  3. Re-verified, no change to tracked fieldsv8
  4. Enrollment target: 400 to 5000v7 Show 5 more changesShow less
    • Primary completion date: Sep 2010 to Apr 2020
    • Study description shortened, about 16 words
    • Site contact updated
    • Collaborators revised (6)
    • Publications: 10 to 18
  5. Enrollment target: 100 to 400v6 Show 4 more changesShow less
    • Primary completion date: Sep 2010
    • Site contact updated
    • Collaborators revised (6)
    • Publications: 9 to 10
  6. Collaborators: 7 to 6v5
  7. Eligibility criteria revisedv4
  8. Study description revised
    • Site contact updated
    • Eligibility criteria expanded, about 3 words
    v3
  9. Enrollment target: 50 to 100v2 Show 5 more changesShow less
    • Study completion date: Apr 2006 to Apr 2020
    • Eligibility criteria expanded, about 8 words
    • Site contact updated
    • Study description expanded, about 2 words
    • Study title expanded, about 1 word
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The researchers aim to investigate the outcome (overall survival) of mothers who are diagnosed and/or treated for cancer during pregnancy. Furthermore they want to test the hypothesis that children who were exposed to cancer or cancer treatment (cytotoxic drugs, radiation therapy, targeted therapy,...) develop normally (neurologic and cardiologic examination).
Trial Details
NCT Number NCT00330447
Lead Sponsor University Hospital, Gasthuisberg
Collaborators: The Netherlands Cancer Institute, Erasmus Medical Center, San Gerardo Hospital, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Charles University, Czech Republic
Conditions
(from sponsor)		 Cancer, Pregnancy
Related terms Neoplasms
Enrollment 5,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov